SMITH SCOTT THOMAS (EVP & Chief Financial Officer) purchased 6.2% of their position (250.00 shares) of ASCENDIS PHARMA A/S on the open market
Open‑market purchase worth $55.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/1/2026ACC: 0001610717-26-000176
Officer· EVP & Chief Financial Officer
Since Mar 2026
+250.00
Net shares
Net buyer
$55.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
250.00 acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+250.00
Price / share
$223.32
Trade value
$55.83K
% of position
6.2%
5/29/2026
4.02K→4.27K
Total
Net shares
+250.00
Net value
$55.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/29/2026 | P · Purchase | +250.00 | $223.32 | $55.83K | 6.2% | 4.02K | 4.27K |
| Total | +250.00 | $55.83K | ||||||
Derivative Transactions0
No derivative transactions reported